437
Views
8
CrossRef citations to date
0
Altmetric
Review Article

Facets of shared decision-making on drug treatment for adults with an eating disorder

ORCID Icon, ORCID Icon, , &
Pages 332-346 | Received 30 Sep 2018, Accepted 16 Jan 2019, Published online: 14 Mar 2019

References

  • American Psychiatric Association. (1980). Diagnostic diagnostic and statistical manual of mental disorders and statistical manual of mental disorders (3rd ed.). Washington, DC: APA Publishing.
  • Andries, A., Frystyk, J., Flyvbjerg, A., & Støving, R. K. (2014). Dronabinol in severe, enduring anorexia nervosa: A randomized controlled trial. The International Journal of Eating Disorders, 47, 18–23. doi:10.1002/eat.22173
  • Arcelus, J., Mitchell, A. J., Wales, J., & Nielsen, S. (2011). Mortality rates in patients with ano-rexia nervosa and other eating disorders. A Meta-Analysis of 36 Studies. Archives of General Psychiatry, 68, 724–731. doi:10.1001/archgenpsychiatry.2011.74
  • Attia, E., Kaplan, A. S., Walsh, B. T., Gershkovich, M., Yilmaz, Z., Musante, D., & Wang, Y. (2011). Olanzapine versus placebo for out-patients with anorexia nervosa. Psychological Medicine, 41, 2177–2182. doi:10.1017/S0033291711000390
  • Barnes, T. R. (1989). A rating scale for drug-induced akathisia. Br J Psychiatry, 154, 672–676. doi:10.1192/bjp.154.5.672
  • Benkert, O., & Hippius, H. (2017). Kompendium der psychiatrischen Pharmakotherapie (11th ed.). Heidelberg, Germany: Springer.
  • Bissada, H., Tasca, G. A., Barber, A. M., & Bradwejn, J. (2008). Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: A randomized, double-blind, placebo-controlled trial. American Journal of Psychiatry, 165, 1281–1288. doi:10.1176/appi.ajp.2008.07121900
  • Bou Khalil, R., Souaiby, L., & Farès, N. (2017). The importance of the hypothalamo-pituitary-adrenal axis as a therapeutic target in anorexia nervosa. Physiology and Behavior, 171, 13–20. doi:10.1016/j.physbeh.2016.12.035
  • Brambilla, F., Garcia, C. S., Fassino, S., Daga, G. A., Favaro, A., Santonastaso, P., … Monteleone, P. (2007). Olanzapine therapy in anorexia nervosa: Psychobiological effects. International Clinical Psychopharmacology, 22, 197–204. doi:10.1097/YIC.0b013e328080ca31
  • Brown, C., & Mehler, P. S. (2014). Anorexia nervosa complicated by diabetes mellitus: The case for permissive hyperglycemia. The International Journal of Eating Disorders, 47, 671–674. doi:10.1002/eat.22282
  • Casiero, D., & Frishman, W. H. (2006). Cardiovascular complications of eating disorders. Cardiology in Review, 14, 227–231. doi:10.1097/01.crd.0000216745.96062.7c
  • Charles, C., Gafni, A., & Whelan, T. (1997). Shared decision-making in the medical encounter: What does it mean? (or it takes at least two to tango). Social Science & Medicine, 44, 681–692. doi:10.1016/S0277-9536(96)00221-3
  • Charles, C., Gafni, A., & Whelan, T. (1999). Decision-making in the physician-patient encounter: Revisiting the shared treatment decision-making model. Social Science & Medicine, 49, 651–661. doi:10.1016/S0277-9536(99)00145-8
  • Coulter, A. (1997). Partnerships with patients: The pros and cons of shared clinical decision-making. Journal of Health Services Research & Policy, 2, 112–121. doi:10.1177/135581969700200209
  • Coulter, A., Edwards, A., Elwyn, G., & Thomson, R. (2011). Implementing shared decision making in the UK. Zeitschrift Für Evidenz, Fortbildung Und Qualität im Gesundheitswesen, 105, 300–304. doi:10.1016/j.zefq.2011.04.014
  • Cuellar, R. E., Kaye, W. H., Hsu, L. K., & Van Thiel, D. H. (1988). Upper gastrointestinal tract dysfunction in bulimia. Digestive Diseases and Sciences, 33, 1549–1553. doi:10.1007/BF01535945
  • da Luz, F. Q., Hay, P., Touyz, S., & Sainsbury, A. (2018). Obesity with comorbid eating disorders: Associated health risks and treatment approaches. Nutrients, 10, 829. doi:10.3390/nu10070829
  • Davis, H., & Attia, E. (2017). Pharmacotherapy of eating disorders. Current Opinion in Psychiatry, 30, 452–457. doi:10.1097/YCO.0000000000000358
  • Della Marca, G., Farina, B., Mennuni, G. F., Mazza, S., Di Giannantonio, M., Spadini, V., … Mazza, M. (2004). Microstructure of sleep in eating disorders: Preliminary results. Eating and Weight Disorders, 9, 77–80. doi:10.1007/BF03325049
  • Department of Health. (2005). Mental Capacity Act. London: HMSO.
  • Department of Health. (2015). Mental Health Act 1983: Code of practice. London: TSO.
  • Dold, M., Aigner, M., Klabunde, M., Treasure, J., & Kasper, S. (2015). Second-generation antipsychotic drugs in anorexia nervosa: A meta-analysis of randomized controlled trials. Psychotherapy and Psychosomatics, 84, 110–116. doi:10.1159/000369978
  • Eddy, K. T., Tabri, N., Thomas, J. J., Murray, H. B., Keshaviah, A., Hastings, E., … Franko, D. L. (2017). Recovery from anorexia nervosa and bulimia nervosa at 22-year follow-up. Journal of Clinical Psychiatry, 78, 184–189. doi:10.4088/JCP.15m10393
  • Fang, F., Sun, H., Wang, Z., Ren, M., Calabrese, J. R., & Gao, K. (2016). Antipsychotic drug-induced somnolence: Incidence, mechanisms, and management. CNS Drugs, 30, 845–867. doi:10.1007/s40263-016-0352-5
  • Frank, G. K., Bailer, U. F., Henry, S. E., Drevets, W., Meltzer, C. C., Price, J. C., … Kaye, W. H. (2005). Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11c]raclopride. Biological Psychiatry, 58, 908–912. doi:10.1016/j.biopsych.2005.05.003
  • Frank, G. K. W., Shott, M. E., Riederer, J., & Pryor, T. L. (2016). Altered structural and effective connectivity in anorexia and bulimia nervosa in circuits that regulate energy and reward homeostasis. Translational Psychiatry, 6, 932.
  • Franke, S., Halfter, S. M., & Himmerich, H. (2010). Diagnosis and therapy of bulimia nervosa. MMW Fortschritte der Medizin, 152, 80–82.
  • Friesen-Storms, J. H., Bours, G. J., van der Weijden, T., & Beurskens, A. J. (2015). Shared decision making in chronic care in the context of evidence based practice in nursing. International Journal of Nursing Studies, 52, 393–402. doi:10.1016/j.ijnurstu.2014.06.012
  • Gable, K. N., & Dopheide, J. A. (2005). Psychotropic medication use at a private eating disorders treatment facility: A retrospective chart review and descriptive data analysis. Current Therapeutic Research, Clinical and Experimental, 66, 572–588. doi:10.1016/j.curtheres.2005.12.011
  • Greenfield, S., Kaplan, S. H., Ware, J. E., Jr., Yano, E. M., & Frank, H. J. (1988). Patients’ participation in medical care: Effects on blood sugar control and quality of life in diabetes. Journal of General Internal Medicine, 3, 448–457. doi:10.1007/BF02595921
  • Guarda, A. S. (2008). Treatment of anorexia nervosa: Insights and obstacles. Physiology & Behavior, 94, 113–120. doi:10.1016/j.physbeh.2007.11.020
  • Guillaume, S., Perroud, N., Jollant, F., Jaussent, I., Olié, E., Malafosse, A., & Courtet, P. (2013). HPA axis genes may modulate the effect of childhood adversities on decision-making in suicide attempters. Journal of Psychiatric Research, 47, 259–265. doi:10.1016/j.jpsychires.2012.10.014
  • Harter, M., Müller, H., Dirmaier, J., Donner-Banzhoff, N., Bieber, C., & Eich, W. (2011). Patient participation and shared decision making in Germany – history, agents and current transfer to practice. Zeitschrift Für Evidenz, Fortbildung Und Qualität im Gesundheitswesen, 105, 263–270. doi:10.1016/j.zefq.2011.04.002
  • Hasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., … Möller, H. J. (2013). WFSBP Task force on Treatment Guidelines for Schizophrenia. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects. World Journal of Biological Psychiatry, 14, 2–44. doi:10.3109/15622975.2012.739708
  • Himmerich, H., Ehrlinger, M., Hackenberg, M., Löhr, B., & Nickel, T. (2006). Possible case of quetiapine-induced rhabdomyolysis in a patient with depression treated with fluoxetine. Journal of Clinical Psychopharmacology, 26, 676–677. doi:10.1097/01.jcp.0000245560.21907.a4
  • Himmerich, H., Joaquim, M., Bentley, J., Kan, C., Dornik, J., Treasure, J., & Schmidt, U. (2018). Psychopharmacological options for adult patients with anorexia nervosa: The patients' and carers' perspectives. CNS Spectrums, 23, 251–252. doi:10.1017/S1092852917000529
  • Himmerich, H., Minkwitz, J., & Kirkby, K. C. (2015). Weight gain and metabolic changes during treatment with antipsychotics and antidepressants. Endocrine, Metabolic & Immune Disorders Drug Targets, 15, 252–260. doi:10.2174/1871530315666150623092031
  • Himmerich, H., Schönknecht, P., Heitmann, S., & Sheldrick, A. J. (2010). Laboratory parameters and appetite regulators in patients with anorexia nervosa. Journal of Psychiatric Practice, 16, 82–92. doi:10.1097/01.pra.0000369969.87779.1c
  • Himmerich, H., Szegedi, A., Klawe, C., Anghelescu, I., & Müller, M. J. (2003). Distigmine bromide induced acute psychotic disorder in a patient with multiple sclerosis. European Psychiatry, 18, 318–319. doi:10.1016/j.eurpsy.2002.11.001
  • Himmerich, H., & Treasure, J. (2018). Psychopharmacological advances in eating disorders. Expert Review of Clinical Pharmacology, 11, 95–108. doi:10.1080/17512433.2018.1383895
  • Jagielska, G. W., Przedlacki, J., Bartoszewicz, Z., & Racicka, E. (2016). Bone mineralization disorders as a complication of anorexia nervosa - etiology, prevalence, course and treatment. Psychiatria Polska, 50, 509–520. doi:10.12740/PP/59289
  • Johns, M. W. (1991). A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep. 14, 540–545. doi:10.1093/sleep/14.6.540
  • Joint Formulary Committee. (2018). British National Formulary 75. London: BMJ Publishing and the Royal Pharmaceutical Society.
  • Jongen, P. J. (2018). Klinische Geneesmiddelprofielen: Een Instrument ter Verbetering van Gezamenlijke Besluitvorming [Clinical drug profiles: An instrument to improve shared decision-making]. Nederlands Tijdschrift Voor Geneeskunde, 162, 2162.
  • Kafantaris, V., Leigh, E., Hertz, S., Berest, A., Schebendach, J., Sterling, W. M., … Malhotra, A. K. (2011). A placebo-controlled pilot study of adjunctive olanzapine for adolescents with anorexia nervosa. Journal of Child and Adolescent Psychopharmacology, 21, 207–212. doi:10.1089/cap.2010.0139
  • Kaplan, S. H., Greenfield, S., & Ware, J. E. Jr. (1989). Assessing the effects of physician- patient interactions on the outcomes of chronic disease. Medical Care, 27, 110–127.
  • Kluge, M., Schacht, A., Himmerich, H., Rummel-Kluge, C., Wehmeier, P. M., Dalal, M., … Schuld, A. (2014). Olanzapine and clozapine differently affect sleep in patients with schizophrenia: Results from a double-blind, polysomnographic study and review of the literature. Schizophrenia Research, 152, 255–260. doi:10.1016/j.schres.2013.11.009
  • Lauer, C. J., & Krieg, J. C. (2004). Sleep in eating disorders. Sleep Medicine Reviews, 8, 109–118. doi:10.1016/S1087-0792(02)00122-3
  • Leblé, N., Radon, L., Rabot, M., & Godart, N. (2017). Manifestations dépressives au cours de l’anorexie mentale: Données de la littérature et implications pour une utilisation adaptée des antidépresseurs [Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants]. L'Encéphale, 43, 62–68. doi:10.1016/j.encep.2016.02.017
  • Légaré, F., & Thompson-Leduc, P. (2014). Twelve myths about shared decision making. Patient Education and Counseling, 96, 281–286. doi:10.1016/j.pec.2014.06.014
  • Levinson, C. A., Rodebaugh, T. L., Fewell, L., Kass, A. E., Riley, E. N., Stark, L., … Lenze, E. J. (2015). D-Cycloserine facilitation of exposure therapy improves weight regain in patients with anorexia nervosa: A pilot randomized controlled trial. The Journal of Clinical Psychiatry, 76, 787–793.
  • Lin, G. A., & Fagerlin, A. (2014). Shared decision making: State of the science. Circulation. Cardiovascular Quality and Outcomes, 7, 328–334. doi:10.1161/CIRCOUTCOMES.113.000322
  • Lingjaerde, O., Ahlfors, U. G., Bech, P., Dencker, S. J., & Elgen, K. (1987). The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatrica Scandinavica, 76(Suppl), 1–100. doi:10.1111/j.1600-0447.1987.tb10566.x
  • Link, T. M., Beermann, U., Mestel, R., & Gander, M. (2017). Stationärer Therapieerfolg bei Patientinnen mit Anorexia Nervosa und komorbiden Persönlichkeitsstörungen - Prävalenz, Therapieabbruch und Gewichtszunahme [Treatment Outcome in Female In-Patients with Anorexia nervosa and Comorbid Personality Disorders – Prevalence, Therapy Drop out and Weight Gain]. Psychotherapie, Psychosomatik, Medizinische Psychologie, 67, 420–430. doi:10.1055/s-0043-103271
  • Luce, K. H., & Crowther, J. H. (1999). The reliability of the Eating Disorder Examination-Self-Report Questionnaire Version (EDE-Q). The International Journal of Eating Disorders, 25, 349–351. doi:10.1002/(SICI)1098-108X(199904)25:3<349::AID-EAT15>3.0.CO;2-M
  • Makoul, G., & Clayman, M. L. (2006). An integrative model of shared decision making in medical encounters. Patient Counselling and Health Education, 60, 301–312. doi:10.1016/j.pec.2005.06.010
  • Martinussen, M., Friborg, O., Schmierer, P., Kaiser, S., Øvergård, K. T., Neunhoeffer, A.-L., … Rosenvinge, J. H. (2017). The comorbidity of personality disorders in eating disorders: A meta-analysis. Eating and Weight Disorders, 22, 201–209. doi:10.1007/s40519-016-0345-x
  • Mazure, C. M., Halmi, K. A., Sunday, S. R., Romano, S. J., & Einhorn, A. M. (1994). The Yale-Brown-Cornell Eating Disorder Scale: Development, use, reliability and validity. Journal of Psychiatric Research, 28, 425–445. doi:10.1016/0022-3956(94)90002-7
  • McCallum, K., Bermudez, O., Ohlemeyer, C., Tyson, E., Portilla, M., & Ferdman, B. (2006). How should the clinician evaluate and manage the cardiovascular complications of anorexia nervosa? Eating Disorders, 14, 73–80. doi:10.1080/10640260500403915
  • Meczekalski, B., Podfigurna-Stopa, A., & Katulski, K. (2013). Long-term consequences of anorexia nervosa. Maturitas, 75, 215–220. doi:10.1016/j.maturitas.2013.04.014
  • Miniati, M., Benvenuti, A., Bologna, E., Maglio, A., Cotugno, B., Massimetti, G., … Dell'Osso, L. (2018). Mood spectrum comorbidity in patients with anorexia and bulimia nervosa. Eat Weight Disord, 23, 305–311. doi:10.1007/s40519-016-0333-1
  • Miniati, M., Mauri, M., Ciberti, A., Mariani, M. G., Marazziti, D., & Dell’Osso, L. (2016). Psychopharmacological options for adult patients with anorexia nervosa. CNS Spectrums, 21, 134–142. doi:10.1017/S1092852914000790
  • Misra, M., & Klibanski, A. (2011). Bone health in anorexia nervosa. Current Opinion in Endocrinology, Diabetes, and Obesity, 18, 376–382. doi:10.1097/MED.0b013e32834b4bdc
  • National Institute for Health and Care Excellence. (2017). Eating disorders: Recognition and treatment (NICE Quality Standard No. 69). Retrieved from https://www.nice.org.uk/guidance/ng69
  • Nielson, S., Emborg, C., & Molbak, A. G. (2002). Mortality in concurrent type 1 diabetes and anorexia nervosa. Diabetes Care, 25, 309–212. doi:10.2337/diacare.25.2.309
  • Overall, J. E., & Gorham, D. R. (1962). The Brief Psychiatric Rating Scale. Psychological Reports, 1962, 10, 799–812. doi:10.2466/pr0.1962.10.3.799
  • Rome, E. S., & Ammerman, S. (2003). Medical complications of eating disorders: An update. J Adolesc Health, 33, 418–426. doi:10.1016/S1054-139X(03)00265-9
  • Rosenbloom, M. H., Schmahmann, J. D., & Price, B. H. (2012). The functional neuroanatomy of decision-making. The Journal of Neuropsychiatry and Clinical Neurosciences, 24, 266–277. doi:10.1176/appi.neuropsych.11060139
  • Sachs, K., & Mehler, P. S. (2016). Medical complications of bulimia nervosa and their treatments. Eating and Weight Disorders, 21, 13–18. doi:10.1007/s40519-015-0201-4
  • Saddoris, M. P., Sugam, J. A., Stuber, G. D., Witten, I. B., Deisseroth, K., & Carelli, R. M. (2015). Mesolimbic dopamine dynamically tracks, and is causally linked to, discrete aspects of value-based decision making. Biological Psychiatry, 77, 903–911. doi:10.1016/j.biopsych.2014.10.024
  • Sánchez-Muniz, F. J., Marcos, A., & Varela, P. (1991). Serum lipids and apolipoprotein B values, blood pressure and pulse rate in anorexia nervosa. European Journal of Clinical Nutrition, 45, 33–36.
  • Santonastaso, P., Sala, A., & Favaro, A. (1998). Water intoxication in anorexia nervosa: A case report. The International Journal of Eating Disorders, 24, 439–442. doi:10.1002/(SICI)1098-108X(199812)24:4<439::AID-EAT12>3.0.CO;2-4
  • Sia, C., Tonniges, T. F., Osterhus, E., & Taba, S. (2004). History of the medical home concept. Pediatrics, 113, 1473–1478.
  • Simpson, G. M., & Angus, J. W. (1970). A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavica. Supplementum, 212, 11–19.
  • Singer, N., Sommer, M., Döhnel, K., Zänkert, S., Wüst, S., & Kudielka, B. M. (2017). Acute psychosocial stress and everyday moral decision-making in young healthy men: The impact of cortisol. Hormones and Behavior, 93, 72–81. doi:10.1016/j.yhbeh.2017.05.002
  • Solmi, M., Veronese, N., Sergi, G., Luchini, C., Favaro, A., Santonastaso, P., … Stubbs, B. (2016). The association between smoking prevalence and eating disorders: A systematic review and meta-analysis. Addiction, 111, 1914–1922. doi:10.1111/add.13457
  • Spaulding-Barclay, M. A., Stern, J., & Mehler, P. S. (2016). Cardiac changes in anorexia nervosa. Cardiology in the Young, 26, 623–628. doi:10.1017/S104795111500267X
  • Spettigue, W., Buchholz, A., Henderson, K., Feder, S., Moher, D., Kourad, K., … Ledoux, S. (2008). Evaluation of the efficacy and safety of olanzapine as an adjunctive treatment for anorexia nervosa in adolescent females: A randomized, double-blind, placebo-controlled trial. BMC Pediatrics, 8, 4. doi:10.1186/1471-2431-8-4
  • Stacey, D., Bennett, C. L., Barry, M. J., Col, N. F., Eden, K. B., Holmes-Rovner, M., … Thomson, R. (2011). Decision aids for people facing health treatment or screening decisions. The Cochrane Database of Systematic Reviews, 10, CD001431.
  • Stheneur, C., Bergeron, S., & Lapeyraque, A. L. (2014). Renal complications in anorexia nervosa. Eat Weight Disorder, 19, 455–460. doi:10.1007/s40519-014-0138-z
  • Szmukler, G. I. (1984). Anorexia nervosa and bulimia in diabetics. Journal of Psychosomatic Research, 28, 365–369. doi:10.1016/0022-3999(84)90067-9
  • Taylor, D. M., Barnes, R. E. B., & Young, A. H. (2018). The Maudsley prescribing guidelines in psychiatry (13th ed.). Hoboken, NJ, USA: Wiley Blackwell.
  • Temmingh, H., & Stein, D. J. (2015). Anxiety in patients with schizophrenia: Epidemiology and management. CNS Drugs, 29, 819–832. doi:10.1007/s40263-015-0282-7
  • The Royal Colleges of Psychiatrists, Physicians and Pathologists. (2014). MARSIPAN: Management of really sick patients with anorexia nervosa (2nd ed.). London, UK. Retrieved from https://www.rcpsych.ac.uk/files/pdfversion/CR189.pdf
  • Tollefson, G. D., & Sanger, T. M. (1999). Anxious-depressive symptoms in schizophrenia: A new treatment target for pharmacotherapy? Schizophrenia Research, 35(Supp. 1), S13–S21. doi:10.1016/S0920-9964(98)00164-9
  • Towle, A., Godolphin, W., Greenhalgh, T., & Gambrill, J. (1999). Framework for teaching and learning informed shared decision making. British Medical Journal, 319, 766–771. doi:10.1136/bmj.319.7212.766
  • Tseng, M. M., Chang, C. H., Liao, S. C., & Chen, H. C. (2017). Comparison of associated features and drug treatment between co-occurring unipolar and bipolar disorders in depressed eating disorder patients. BMC Psychiatry, 17, 81. doi:10.1186/s12888-017-1243-0
  • Tyrrell-Bunge, E., de Carvalho, A. F., Scott, C., Tomlin, S., Treasure, J., & Himmerich, H. (2018). A three level-intervention to reduce PRN medication on a specialist eating disorders ward for adult female patients with anorexia nervosa. Psychiatria Danubina, 30, 107–108.
  • Ulfvebrand, S., Birgegård, A., Norring, C., Högdahl, L., & von Hausswolff-Juhlin, Y. (2015). Psychiatric comorbidity in women and men with eating disorders results from a large clinical database. Psychiatry Research, 230, 294–249. doi:10.1016/j.psychres.2015.09.008
  • Ulrich-Lai, Y. M., Fulton, S., Wilson, M., Petrovich, G., & Rinaman, L. (2015). Stress exposure, food intake and emotional state. Stress, 18, 381–399.
  • Weschenfelder, J., Bentley, J., & Himmerich, H. (2018). Physical and mental health consequences of obesity in women. In L. Szablewski (Ed.), Adipose tissue (pp. 123–159). London, UK: InTech Open.
  • Weston, W. W. (2001). Informed and shared decision-making: The crux of patient-centered care. Canadian Medical Association Journal, 165, 438–439.
  • Williams, P. M., Goodie, J., & Motsinger, C. D. (2008). Treating eating disorders in primary care. American Family Physician, 77, 187–195.
  • Winston, A. P. (2012). The clinical biochemistry of anorexia nervosa. Annals of Clinical Biochemistry, 49, 132–143. doi:10.1258/acb.2011.011185
  • Winston, A. P., Jamieson, C. P., Madira, W., Gatward, N. M., & Palmer, R. L. (2000). Prevalence of thiamin deficiency in anorexia nervosa. The International Journal of Eating Disorders, 28, 451–454. doi:10.1002/1098-108X(200012)28:4<451::AID-EAT14>3.0.CO;2-I

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.